Diisocyanates are well-recognized causes of
asthma. However, sensitized workers frequently lack diisocyanate-specific
IgE, which complicates diagnosis and suggests the disease involves
IgE-independent mechanisms. We used a mouse model of
methylene diphenyl diisocyanate (MDI)
asthma to identify
biological pathways that may contribute to
asthma pathogenesis. MDI sensitization and respiratory tract exposure were performed in Balb/c, transgenic B-cell (e.g.,
IgE)-deficient mice and a genetic background (C57BL/6)-matched strain. Eosinophils in airway fluid were quantitated by flow cytometry. Lung tissue gene expression was assessed using whole-genome
mRNA microarrays. Informatic software was used to identify
biological pathways affected by respiratory tract exposure and potential targets for disease intervention. Airway
eosinophilia and changes (>1.5-fold; P value < 0.05) in expression of 192 genes occurred in all three mouse strains tested, with enrichment in
chemokines and a pattern associated with alternatively activated monocytes/macrophages. CLCA1 (
calcium-activated chloride channel regulator 1) was the most upregulated gene transcript (>100-fold) in all exposed mouse lungs versus controls, followed closely by SLC26A4, another transcript involved in Cl- conductance.
Crofelemer, a U.S. Food and Drug Administration-approved Cl- channel inhibitor, reduced MDI exposure induction of airway
eosinophilia, mucus, CLCA1, and other
asthma-associated gene transcripts. Expression changes in a core set of genes occurs independent of
IgE in a mouse model of chemical-induced airway
eosinophilia. In addition to
chemokines and alternatively activated monocytes/macrophages, the data suggest a crucial role for Cl- channels in diisocyanate
asthma pathology and as a possible target for intervention.